PFE Pfizer Inc.
$28.67
Pfizer Inc. (PFE) is confirmed to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.77 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +14.5% since its last earnings release on August 4, 2026.
Pfizer Beat Expectations, Narrows Revenue Guidance
Tuesday, August 4, 2026 · 6:45 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs $0.77
Rev est $16.25B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$27.55
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Pfizer Inc.
Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 13 ETFs, by dollar flow
- BUZZ Vaneck Social Sentiment ETF
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- MOAT VanEck Morningstar Wide Moat ETF
- IYH iShares U.S. Healthcare ETF
- DVY iShares Select Dividend ETF
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
Charts powered in part by Lightweight Charts™ by TradingView.